L-031

左乙拉西坦-D ₆ 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 别名: 左乙拉西坦-D ₆ 溶液
• 经验公式（希尔记法）: C₈D₆H₈N₂O₂
• 分子量: 176.25
• EC號碼: 200-659-6
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: Snap-N-Spike^®/Snap-N-Shoot^®
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 1.0 mg/mL in methanol
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: clinical testing
• 格式: single component solution
• 儲存溫度: −20°C
• SMILES 字串: [2H]C([2H])([2H])C([2H])([2H])C([2H])(N1CCCC1=O)C(N)=O
• InChI: 1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/i1D3,2D2
• InChI 密鑰: HPHUVLMMVZITSG-ZBJDZAJPSA-N

说明

一般說明

适合在法医分析、临床毒理学、疼痛处方监测或尿液药物测试中，作为内参标准品用于左乙拉西坦的GC/MS或LC/MS测试或同位素稀释方法。左乙拉西坦，以商品名Keppra出售^®，是一种抗癫痫药，主要用于治疗癫痫发作，并偶尔用于治疗神经性疼痛。

應用

• Pharmaceutical reference standards: Levetiracetam-D₆ is utilized as a pharmaceutical reference standard in the development and validation of bioanalytical methods. A study by Nikolaou et al. employed this stable-labeled compound in gas chromatography with mass spectrometry for the quantification of lacosamide in human plasma, demonstrating its crucial role in therapeutic drug monitoring (Nikolaou et al., 2015).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Keppra is a registered trademark of UCB Pharma, S.A.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225 - H301 + H311 + H331 - H370
• 防範說明: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup